About this conference
ICBIB is a 1-day conference in Sydney, Australia on 3 Jan 2027. Abstract deadline: 2 Dec 2026. Fees: 30 - 400 USD. Organizer: iPHARMA Conferences.
This event convenes experts from biopharmaceutical and regulatory fields to address advancements in drug development and the integration of biosimilars into therapeutic practices. Participants will engage in discussions surrounding the scientific principles, regulatory processes, and market strategies inherent in biopharmaceutical innovations. Sessions will be conducted through presentations, panel discussions, and poster exhibitions, allowing for comprehensive insights into both theoretical and practical aspects. Researchers are invited to submit abstracts for oral and poster formats, contributing to the enriching discussions. The conference will provide a thorough exploration of the implications for patient care and community health, fostering dialogues aimed at improving access and efficacy of biopharmaceutical products. Attendees can expect to contribute to a collaborative atmosphere that encourages future development pathways within the industry and academia.